CME Corner

This activity has expired. CME/CE credit is no longer available and the following content may not be available or may not be up-to-date. For a list of current activities that offer CME/CE credit, click here.

Program Detail

Program Title

Optimizing Control: Type 2 Diabetes and Early Insulin Initiation
Release Date: October-19-05
Credit Expiration Date: December-31-06


Allison K. Wick, MSN, ARNP-BC, CDE
Family Nurse Practitioner
Diabetes Research Institute
University of Miami
Miami, Florida

Credit Hours

1.2 contact hours


Online Presentation

Program Description

Diabetes is one of the most costly and debilitating diseases worldwide and the acute complications that accompany the condition are a major cause of morbidity and mortality. Despite an increase in public awareness over the last decade, the disease continues to become more prevalent year after year. By 2030, it is estimated that the number of worldwide cases of diabetes will surge to 366 million, due to population growth, aging, urbanization, and an increase in obesity and inactivity.

This program reviews the evidence supporting aggressive treatment directed at decreasing the incidence of diabetes complications. It details the use of insulin therapy as an effective option, which in the past has been underutilized and delayed until years after the disease has progressed.

Program Developer/Facilitator


Target Audience

Nurse practitioners. This program has been approved for 1.2 contact hours of continuing education by the American Academy of Nurse Practitioners.

Learning Objectives

Upon completion of this educational activity, the participant should be able to:

  1. Describe the epidemiologic burden of disease in type 2 diabetes.
  2. Discuss the rationale for improving metabolic control.
  3. Identify and discuss options for when and how to initiate insulin therapy.
  4. Review the pathophysiology of type 2 diabetes.


Allison K. Wick discloses that she is a member of a speakers’ bureau for Aventis and has received an honorarium from Novo Nordisk.

Credit Statements

This program has been approved for 1.2 contact hours of continuing education by the American Academy of Nurse Practitioners. Program ID 0502098.

Commercial Support Statements

This activity is supported through an educational grant from Novo Nordisk.


  1. Click on the "Start program" icon. If you are not already logged in to the site, this will bring you to the login/registration page where you will be able to register as a new member or check existing registration information. When ready, click on the "Continue to Program" icon at the bottom of the screen.
  2. Clicking on "start the program" on this screen will bring you to instructions to turn off pop-up blockers and allow you to begin the program presentation which will take approximately 60 minutes to complete.
  3. Upon completion of the program, click on the post-test button to register and access the post-test and program evaluation.
  4. Instructions for completing and submitting the post-test are provided on the post-test screen. A minimum score of 70% on the post-test is required for a CE certificate.
  5. The next screen will permit you to check for or download the Flash player required to run this program.

Certificate Fee



None of the contents of this activity may be reproduced in any form without prior written permission from the publisher. The opinions expressed in this activity are those of the presenter and do not necessarily reflect the opinions or recommendations of her affiliated institution, the publisher, AANP, or Novo Nordisk. Any medications, diagnostic procedures, or treatments discussed by the program presenter should not be used by clinicians or other healthcare professionals without first evaluating their patients’ conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.

By clicking START PROGRAM I acknowledge that I have read the CME/CE information above.

Main Menu